Print Page

给 医 护 专 业 人 员 的 信
 
PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine (English only) (Letter to Healthcare Professionals)
 
 
 
附件:
  1. PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine (English only)  
Related Information:
Singapore: Pseudoephedrine and the rare risk of posterior reversible encephalopa... 上载于 2024-04-29
Singapore: Zyrtec-D: Risks of posterior reversible encephalopathy syndrome and r... 上载于 2024-03-18
The United Kingdom: Pseudoephedrine: very rare risk of posterior reversible ence... 上载于 2024-02-21
European Union: EMA confirms measures to minimise the risk of serious side effec... 上载于 2024-01-27
European Union: PRAC recommends measures to minimise the risk of serious side ef... 上载于 2023-12-02
The United Kingdom: MHRA safety review of medicines containing pseudoephedrine (... 上载于 2023-02-27
European Union: PRAC starts safety review of pseudoephedrine-containing medicine... 上载于 2023-02-11
 
back